Bayer AG PK Financials

BAYRYDelisted Stock  USD 16.86  0.86  5.37%   
You can use fundamental analysis to find out if Bayer AG PK is mispriced or if you can make any profits on it by purchasing it and then waiting for the market to recognize its mistake and reprise the security. We were able to interpolate data for thirty-seven available fundamental indicators for Bayer AG PK, which can be compared to its rivals. To ensure the equity is not overpriced, please confirm all Bayer AG PK financials, including its earnings per share, and the relationship between the cash per share and total asset . Given that Bayer AG PK has a price to sales of 1.02 X, we suggest you to validate Bayer AG PK prevailing market performance to make sure the company can sustain itself down the road. The stock experiences a very speculative upward sentiment. The trend is possibly hyped up. Check odds of Bayer AG to be traded at $21.08 in 90 days.
With this module, you can analyze Bayer financials for your investing period. You should be able to track the changes in Bayer AG individual financial statements over time to develop the understanding of its risk, liquidity, profitability, or other critical and vital indicators.
  
Understanding current and past Bayer AG Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Bayer AG's financial statements are interrelated, with each one affecting the others. For example, an increase in Bayer AG's assets may result in an increase in income on the income statement.
Evaluating Bayer AG's financials involves analyzing a range of financial metrics and ratios to gain insights into the company's financial health and performance. However, considering all of Bayer AG's profitability, liquidity ratios, and efficiency indicators at the same time could be an enormous task, and our Financial Distress score can provide you with a snapshot of the Bayer AG's relative financial performance

Chance Of Distress

Over 100

 
100  
 
Zero
Dangerous
Bayer AG PK has more than 100 (%) percent chance of experiencing financial distress in the next two years of operations. The calculation of odds of distress for Bayer AG pink sheet is tightly coupled with the Probability of Bankruptcy. It complements the equity performance score by supplying investors with insight into company financials without requiring them to know too much about all of the complex accounting and financial indicators surrounding the entity.
Please note, Bayer AG's odds of distress score SHOULD NOT be confused with the real chance of Bayer AG PK filing for bankruptcy protection for chapters 7, 11, 12, or 13. We define Financial Distress as an operational condition where an entity such as Bayer is having difficulty meeting its current financial obligations towards its creditors or delivering on the expectations of its investors. Macroaxis derives these conditions daily from public financial statements and analysis of stock prices reacting to market conditions or economic downturns, including short-term and long-term historical volatility. Other factors considered include Bayer AG's liquidity analysis, revenue patterns, R&D expenses, and commitments, as well as public headlines and social sentiment.
More Info
The data published in Bayer AG's official financial statements usually reflect Bayer AG's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Bayer AG PK. For example, before you start analyzing numbers published by Bayer accountants, it's critical to develop an understanding of what Bayer AG's liquidity, profitability, and earnings quality are in the context of the Pharmaceuticals space in which it operates.
Please note, the presentation of Bayer AG's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Bayer AG's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Bayer AG's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Bayer AG PK. Please utilize our Beneish M Score to check the likelihood of Bayer AG's management manipulating its earnings.

Bayer AG Company Summary

Bayer AG competes with Broadleaf, Bm Technologies, United Airlines, Zhihu, and Datadog. Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. Bayer Aktiengesellschaft was founded in 1863 and is headquartered in Leverkusen, Germany. Bayer Aktienges is traded on OTC Exchange in the United States.
Specialization
Healthcare, Biotechnology
InstrumentUSA Pink Sheet View All
ExchangePINK Exchange
ISINUS0727303028
CUSIP072730302
LocationGermany
Business AddressKaiser-Wilhelm-Allee 1, Leverkusen,
SectorPharmaceuticals
IndustryHealth Care
BenchmarkNYSE Composite
Websitewww.bayer.com
Phone49 214 30 1
CurrencyUSD - US Dollar
You should never invest in Bayer AG without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Bayer Pink Sheet, because this is throwing your money away. Analyzing the key information contained in Bayer AG's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.

Bayer AG Key Financial Ratios

Generally speaking, Bayer AG's financial ratios allow both analysts and investors to convert raw data from Bayer AG's financial statements into concise, actionable information that can be used to evaluate the performance of Bayer AG over time and compare it to other companies across industries. There are many critical financial ratios that investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Bayer AG PK reports annually and quarterly.

Bayer Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Bayer AG's current stock value. Our valuation model uses many indicators to compare Bayer AG value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Bayer AG competition to find correlations between indicators driving Bayer AG's intrinsic value. More Info.
Bayer AG PK is number one stock in target price category among related companies. It is number one stock in shares outstanding category among related companies creating about  261,980,006  of Shares Outstanding per Target Price. . Comparative valuation analysis is a catch-all model that can be used if you cannot value Bayer AG by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Bayer AG's Pink Sheet . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Bayer AG's earnings, one of the primary drivers of an investment's value.

Bayer AG Market Pulse

 Quote16.86
 Change(%)  5.37 
 Change0.86 
 Open16.0
 Low15.88
 High16.91
 Volume0
 ExchangePINK

About Bayer AG Financials

What exactly are Bayer AG Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include Bayer AG's income statement, its balance sheet, and the statement of cash flows. Potential Bayer AG investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although Bayer AG investors may use each financial statement separately, they are all related. The changes in Bayer AG's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Bayer AG's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.

Steps to analyze Bayer AG Financials for Investing

There are several different ways that investors can use financial statements to try and predict whether a stock price will go up or down. Unfortunately, there is no surefire formula, but there are some general guidelines you should consider when looking at the numbers. First, realize what kind of company it is so you know if its revenues are more likely to grow or shrink over time. For example, a software company's revenue is expected to increase yearly due to new products and services that its customers will want to buy. At the same time, a car manufacturer might not be able to sell as many cars when the economy slows down, so it would have less net income during those times. Second, pay attention to its debt-to-equity ratio because this number will tell you how much risk it has. If a company such as Bayer AG is not taking on any additional risks, its debt-to-equity should be less than one. As a general rule of thumb, if the market value or book value (which can be found in the footnotes) of assets exceeds the company's liabilities, then it is probably in good shape. Finally, use other financial statements to determine if a stock price will go up or down because investors are always looking for growth opportunities when they buy new stocks. For example, if you see that the net revenue of Bayer has grown by more than 25% over the last five years, then there is a good chance that it will continue growing by at least 20% or more each year. On the other hand, if you see that net revenue has only increased by about 15%, which is barely above inflation levels, then chances are it will not grow much faster than this over time, and investors may shy away from buying it.
In summary, you can determine if Bayer AG's financials are consistent with your investment objective using the following steps:
  • Review Bayer AG's balance sheet accounts, such as liabilities and equity, to understand its overall financial position.
  • Analyze the income statement and examine the company's revenue, expenses, and profits over time to determine its financial performance.
  • Study the cash flow inflows and outflows to understand Bayer AG's liquidity and solvency.
  • Look at the growth rates in revenue, earnings, and cash flow over time to determine its potential for future growth.
  • Compare Bayer AG's financials to those of its peers to see how it stacks up and identify any potential red flags.
  • Use valuation ratios to evaluate the company's financials using commonly used ratios such as the price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and enterprise value-to-earnings before interest, taxes, depreciation, and amortization (EV/EBITDA) ratio to determine if Bayer AG's stock is overvalued or undervalued.
Remember, these are just guidelines and should not be the only basis for investment decisions. It is always important to analyze the leading stock market indicators., conduct additional research and seek professional advice if needed.

Bayer AG March 29, 2024 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Bayer AG help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Bayer AG PK. We use our internally-developed statistical techniques to arrive at the intrinsic value of Bayer AG PK based on widely used predictive technical indicators. In general, we focus on analyzing Bayer Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Bayer AG's daily price indicators and compare them against related drivers.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.

Other Consideration for investing in Bayer Pink Sheet

If you are still planning to invest in Bayer AG PK check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Bayer AG's history and understand the potential risks before investing.
Commodity Directory
Find actively traded commodities issued by global exchanges
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation